Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03528603 · ClinicalTrials.gov registry record · NA
Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03528603 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 26 participants.
The verdict
NCT03528603, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The investigators have previously observed a reduced level of platelet aggregation 2 hours after healthy male individuals were asked to drink extra virgin olive oil (EVOO) that provided a higher level of one specific phenolic known as oleocanthal. This study will help the investigators further determine the effects of oleocanthal-rich EVOO intake on platelet function at 2, 4 and 6 hours after intake with food compared to platelet function in the morning after an overnight fast.
Interventions
- OTHER Oleocanthal-Rich Extra Virgin Olive Oil
- OTHER Oleocanthal-low Extra Virgin Olive Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03528603
The ClinicalTrials.gov registry entry for NCT03528603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oleocanthal-Rich Extra Virgin Olive Oil is the first listed.
NCT03528603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03528603 about?
NCT03528603 is a clinical study titled "Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal". The investigators have previously observed a reduced level of platelet aggregation 2 hours after healthy male individuals were asked to drink extra virgin olive oil (EVOO) that provided a higher level of one specific phenolic known as oleocanthal. This study will help the investigators further deter...
What is the current status of trial NCT03528603?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-04-02. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT03528603?
The interventions under investigation include: Oleocanthal-Rich Extra Virgin Olive Oil (OTHER), Oleocanthal-low Extra Virgin Olive Oil (OTHER).
Who is sponsoring clinical trial NCT03528603?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.